Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome
Year: 2020
Type: review
Abstract: Recent research on extracellular vesicles (EVs) has provided new insights into pathogenesis and potential therapeutic options for acute respiratory distress syndrome (ARDS). EVs are membrane-bound anuclear structures that carry important intercellular communication mechanisms, allowing targeted transfer of diverse biologic cargo, including protein, mRNA, and microRNA, among several different cell types. In this review, we discuss the important role EVs play in both inducing and attenuating inflammatory lung injury in ARDS as well as in sepsis, the most important clinical cause of ARDS. We discuss the translational challenges that need to be overcome before EVs can also be used as prognostic biomarkers in patients with ARDS and sepsis. We also consider how EVs may provide a platform for novel therapeutics in ARDS.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: G1500196695, Can combined cellular and 11beta-hydroxysteroid dehydrogenase-1 gene therapy attenuate inflammation in acute respiratory distress syndrome?, Albumin Nanoparticles Incorporating Piceatannol (PANPs) for ALI/ARDS therapy, HLS13-13 Albumin nanoparticle based technology to treat ARDS, Precision Medicine in the Acute Respiratory Distress Syndrome, Novel exosomal niches for alveolar stem cell-bassed repair of ARDS
OpenAlex ID: W3007923702
